| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2341041.9 | $2328025.1 | $1627859.12 | $1882888.9 |
| Short term investments | ||||
| Net receivables | $690756.7 | $551889.2 | $1942187.6 | |
| Inventory | $115.23 | |||
| Total current assets | $3031798.6 | $2879914.3 | $6542289.22 | $3825076.5 |
| Long term investments | $18686810.6 | $18213294.4 | $17764898.99 | $17712803.5 |
| Property, plant & equipment | $436075 | $438005.7 | $395100.3 | $395864.6 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $56016909.6 | $53976503.1 | $53608835.29 | $51775457.8 |
| Current liabilities | ||||
| Accounts payable | $42303422.2 | $40813099.1 | $40874106.01 | $38827998.8 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $42303422.2 | $40813099.1 | $41413239.57 | $38827998.8 |
| Long term debt | $5157220.2 | $5045936.6 | $4491597.84 | $5188068.9 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $52564077.6 | $50680311.6 | $50440880.62 | $48648624 |
| Shareholders' equity | ||||
| Retained earnings | $1672067.51 | |||
| Other shareholder equity | $3322309.6 | $3171057 | $583733.63 | $3009727.8 |
| Total shareholder equity | $3331234.2 | $3179981.6 | $3055880.45 | $3018652.4 |
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1627859.12 | $1578997.44 | $1076817.52 | $672938.07 |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | $115.23 | $104.96 | $145.45 | $236.58 |
| Total current assets | $6542289.22 | $5910172.22 | $4819177.59 | $4175283.41 |
| Long term investments | $17764898.99 | $15951002.66 | $12282842.78 | $11192698.16 |
| Property, plant & equipment | $395100.3 | $401667.88 | $400781.68 | $407030.53 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $53608835.29 | $48456185.47 | $41974923.44 | $38884641.96 |
| Current liabilities | ||||
| Accounts payable | $40874106.01 | $37153312.42 | $32741606.25 | $29405410.61 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $41413239.57 | $37484625.62 | $33166569.8 | $30004424.06 |
| Long term debt | $4491597.84 | $4337962.08 | $3329006.7 | $4137476.61 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $50440880.62 | $45604310.7 | $39384883.98 | $36479315.44 |
| Shareholders' equity | ||||
| Retained earnings | $1672067.51 | $1432030.91 | $1220024.97 | $1124211.21 |
| Other shareholder equity | $583733.63 | $523505.37 | $490496.96 | $420666.08 |
| Total shareholder equity | $3055880.45 | $2755615.6 | $2510601.24 | $2344956.6 |
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $661193.2 | $478306.6 | $465991.77 | $577231.4 |
| Cost of revenue | ||||
| Gross Profit | $661193.2 | $478306.6 | $465991.77 | $577231.4 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $139653.9 | $131373.3 | $412985.98 | $134715.5 |
| Total operating expenses | $457768.4 | $375655.5 | $535423.36 | $445733.8 |
| Operating income | $203424.8 | $102651.1 | -$69431.59 | $131497.6 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $53252 | $27368.6 | -$95185.3 | $34578 |
| Interest expense | ||||
| Net income | ||||
| Net income | $147520 | $73251.1 | $95491.3 | $95550 |
| Income (for common shares) | $147520 | $73251.1 | $95491.3 | $95550 |
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2107195.97 | $1733420.45 | $1441768.31 | $1174029.02 |
| Cost of revenue | ||||
| Gross Profit | $2107195.97 | $1733420.45 | $1441768.31 | $1174029.02 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $817223.89 | $732218.98 | $673098.14 | $611819.82 |
| Total operating expenses | $1743634.26 | $1504295.95 | $1317815.63 | $1148003.08 |
| Operating income | $363561.71 | $229124.49 | $123952.68 | $26025.94 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | $353738.8 | $224054.58 | $197678.02 | $22996.39 |
| Income (for common shares) | $353738.8 | $224054.58 | $197678.02 | $22996.39 |
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Net income | $147520 | $73251.1 | $95491.3 | $95550 |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | ||||
| Effect of exchange rate | ||||
| Change in cash and equivalents | ||||
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Net income | $353738.8 | $224054.58 | $197678.02 | $22996.39 |
| Operating activities | ||||
| Depreciation | $36912.7 | $37110.64 | $36615.58 | $34958.92 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$3143845.13 | -$3512516.86 | -$3096910.33 | -$1888067.74 |
| Investing activities | ||||
| Capital expenditures | -$33052.6 | -$38280.2 | -$30650.11 | -$30055.1 |
| Investments | ||||
| Total cash flows from investing | -$36185.13 | -$37362.27 | -$33236.93 | -$8567.74 |
| Financing activities | ||||
| Dividends paid | -$35698.45 | |||
| Sale and purchase of stock | ||||
| Net borrowings | $35557 | $105333.36 | $84958.18 | $33776 |
| Total cash flows from financing | $3682348.45 | $4483132.87 | $3390490.82 | $2188104.17 |
| Effect of exchange rate | $9662.67 | $663.99 | $27686.43 | $10762.87 |
| Change in cash and equivalents | $511980.86 | $933917.72 | $288030 | $302231.56 |
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $2.18T |
|---|---|
| EBITDA | N/A |
| EBIT | $0.00 |
| Net Income | $411.81B |
| Revenue Q/Q | 6.83% |
| Revenue Y/Y | 9.42% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | 0.76% |
| ROE | 13.09% |
| Debt/Equity | 16.51 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.07 |
| Quick ratio | N/A |